Acorda Therapeutics Inc (NASDAQ:ACOR)

23.35
Delayed Data
As of Apr 20
 -0.05 / -0.21%
Today’s Change
13.60
Today|||52-Week Range
29.60
+8.86%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues401.5M492.7M519.6M588.3M
 
 
 
 
 
Cost of Goods Sold72.1M77.9M86.5M99.6M
 
 
 
 
 
Depreciation And Amortization8.5M15.0M21.6M36.1M
 
 
 
 
 
 
Operating ExpensesGross Income320.9M399.7M411.5M452.6M
 
 
 
 
 
General Expenses268.5M354.8M421.3M343.0M
 
 
 
 
 
Research And Development73.5M149.2M203.4M160.6M
 
 
 
 
 
Total Operating Expenses349.1M447.8M529.4M478.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income52.4M44.9M-9.8M109.6M
 
 
 
 
 
Extraordinary Credit236.0K0.00----
 
 
Extraordinary Charge-16.4M-10.9M-26.2M-345.9M
 
 
 
 
 
Interest Expense On Debt9.3M15.5M16.5M18.7M
 
 
 
 
 
Other Expenses379.0K411.0K9.9M3.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income28.0M19.4M-42.3M-251.9M
 
 
 
 
 
Income Taxes-10.3M-8.3M-6.7M-28.5M
 
 
 
 
 
Minority Interest0.000.00-985.0K0.00
 
 
Net Income17.7M11.1M-34.6M-223.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS41.2M42.2M45.3M46.0M
 
 
 
 
 
Shares To Calculate EPS Diluted42.5M43.6M45.3M46.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.42$0.25-$0.76-$4.86
 
 
 
 
 
EPS Diluted$0.42$0.25-$0.76-$4.86